Category Archives: BioEngineering

Global Bio-decontamination Equipment Market Forecast 2026 By Top Players, Applications, and its Types.

Global Bio-decontamination Equipment Market Research Report focuses on delevering the up-to-date and latest growth opportunities, 360-degree market overview, statistical data of Bio-decontamination Equipment industry. Bio-decontamination Equipment market size, share, revenue, growth rate, Consumption, company profile, and leading players are analyzed for the period 2019-2026.

The report highlights industry overview, growth trajectory, market dynamics, market share analyzed in detail this report. Bio-decontamination Equipment report numbers are driven by past, present and forecast market trends, development opportunities, market risks, and maturity analysis.

The report gives indepth analysis by segmenting the overall Bio-decontamination Equipment market based on type, application, end user and regions. Bio-decontamination Equipment type segment gives the in depth analysis of the global market share, production value and volume, price trends and growth rate exibited by each product type from 2014 to 2019.

Get Free Sample Report with Latest Bio-decontamination Equipment Industry Trends: https://www.reportspedia.com/report/chemicals-and-materials/global-bio-decontamination-equipment-market-research-report-2014-2026-of-major-types,-applications-and-competitive-vendors-in-top-regions-and-countries/43947#request_sample

Market Segmented:

By Key Players Of the Bio-decontamination Equipment Market.

Fedegari GroupSTERIS Life ScienceBioquellWeike Biological LaboratoryHoworth Air TechnologyTailin BioEngineeringNoxilizerJCE BiotechnologyTOMI Environmental Solutions

By Type

Wall-mounted purification equipmentHanging purification equipmentCeiling-type purification equipmentFloor-standing purification equipment

By Application

ResidentialOfficemanufacturingHospital & HealthcareOthers

Bio-decontamination Equipment application fragment discusses the consumption ratio, market share, downstream buyers and growth rate from 2014 to 2019. Bio-decontamination Equipment fragment on regional level covers the market share, utilization, and production capacity, gross margin analysis for the regions namely North America, Europe, Asia-Pacific, Middle East & Africa, and South America

Get Discount on this Premium Report:https://www.reportspedia.com/report/chemicals-and-materials/global-bio-decontamination-equipment-market-research-report-2014-2026-of-major-types,-applications-and-competitive-vendors-in-top-regions-and-countries/43947#inquiry_before_buying

It offers strategic market view by segmenting the overall market based on product type, application, end user and research regions. Key insights on global, regional and country level are presented in this report. The leading Bio-decontamination Equipment players are analyzed on the basis of recent developments, production value & volume, growth rate, and geographical presence. These Bio-decontamination Equipment industry players, regional geography, applications, and product type can be custom-made based on users requirement.

The valuable Bio-decontamination Equipment market insights like upstream raw material analysis, production process analysis, labor cost, raw material cost are covered in this report. Gross margin analysis, consumption ratio, Bio-decontamination Equipment import-export scenario, and SWOT analysis is presented in this report. The forecast Bio-decontamination Equipment industry insights pertaining to market value, volume, consumption will shape the future business growth.

Attractions Of The Report

Latest market dynamics, development trends and growth opportunities are presented along with industry barriers, developmental threats and risk factors

The forecast Bio-decontamination Equipment data will help in the feasibility analysis, market size estimation and development scope.

The report serves as a complete guide which micro monitors all vital Bio-decontamination Equipment segments.

A concise market view will provide ease of understanding.

Bio-decontamination Equipment Competitive market view will help the players in making a right move

Table Of Content:

1 Global Market Overview

1.1 Scope of Statistics

Scope of Products

Scope of Manufacturers

Scope of Application

Scope of Type

Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

Regional Production

Regional Demand

Regional Trade

3 Key Manufacturers Information

Company Information

Product & Services

Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)Recent Development

More

Browse Full Report with Facts and Figures of Bio-decontamination Equipment Market Report at:https://www.reportspedia.com/report/chemicals-and-materials/global-bio-decontamination-equipment-market-research-report-2014-2026-of-major-types,-applications-and-competitive-vendors-in-top-regions-and-countries/43947#table_of_contents

See the original post:
Global Bio-decontamination Equipment Market 2019- Industry Innovative Growth with SWOT Analysis and Forecast-2026 - BulletintheNews

Every year, a lack of vaccination leads to about 1.5 million preventable deaths, primarily in developing nations. One factor that makes vaccination campaigns in those nations more difficult is that there is little infrastructure for storing medical records, so theres often no easy way to determine who needs a particular vaccine.

MIT researchers have now developed a novel way to record a patients vaccination history: storing the data in a pattern of dye, invisible to the naked eye, that is delivered under the skin at the same time as the vaccine.

In areas where paper vaccination cards are often lost or do not exist at all, and electronic databases are unheard of, this technology could enable the rapid and anonymous detection of patient vaccination history to ensure that every child is vaccinated, says Kevin McHugh, a former MIT postdoc who is now an assistant professor of bioengineering at Rice University.

The researchers showed that their new dye, which consists of nanocrystals called quantum dots, can remain for at least five years under the skin, where it emits near-infrared light that can be detected by a specially equipped smartphone.

McHugh and former visiting scientist Lihong Jing are the lead authors of the study, which appears today in Science Translational Medicine. Ana Jaklenec, a research scientist at MITs Koch Institute for Integrative Cancer Research, and Robert Langer, the David H. Koch Institute Professor at MIT, are the senior authors of the paper.

An invisible record

Several years ago, the MIT team set out to devise a method for recording vaccination information in a way that doesnt require a centralized database or other infrastructure. Many vaccines, such as the vaccine for measles, mumps, and rubella (MMR), require multiple doses spaced out at certain intervals; without accurate records, children may not receive all of the necessary doses.

In order to be protected against most pathogens, one needs multiple vaccinations, Jaklenec says. In some areas in the developing world, it can be very challenging to do this, as there is a lack of data about who has been vaccinated and whether they need additional shots or not.

To create an on-patient, decentralized medical record, the researchers developed a new type of copper-based quantum dots, which emit light in the near-infrared spectrum. The dots are only about 4 nanometers in diameter, but they are encapsulated in biocompatible microparticles that form spheres about 20 microns in diameter. This encapsulation allows the dye to remain in place, under the skin, after being injected.

The researchers designed their dye to be delivered by a microneedle patch rather than a traditional syringe and needle. Such patches are now being developed to deliver vaccines for measles, rubella, and other diseases, and the researchers showed that their dye could be easily incorporated into these patches.

The microneedles used in this study are made from a mixture of dissolvable sugar and a polymer called PVA, as well as the quantum-dot dye and the vaccine. When the patch is applied to the skin, the microneedles, which are 1.5 millimeters long, partially dissolve, releasing their payload within about two minutes.

By selectively loading microparticles into microneedles, the patches deliver a pattern in the skin that is invisible to the naked eye but can be scanned with a smartphone that has the infrared filter removed. The patch can be customized to imprint different patterns that correspond to the type of vaccine delivered.

Its possible someday that this invisible approach could create new possibilities for data storage, biosensing, and vaccine applications that could improve how medical care is provided, particularly in the developing world, Langer says.

Effective immunization

Tests using human cadaver skin showed that the quantum-dot patterns could be detected by smartphone cameras after up to five years of simulated sun exposure.

The researchers also tested this vaccination strategy in rats, using microneedle patches that delivered the quantum dots along with a polio vaccine. They found that those rats generated an immune response similar to the response of rats that received a traditional injected polio vaccine.

This study confirmed that incorporating the vaccine with the dye in the microneedle patches did not affect the efficacy of the vaccine or our ability to detect the dye, Jaklenec says.

The researchers now plan to survey health care workers in developing nations in Africa to get input on the best way to implement this type of vaccination record keeping. They are also working on expanding the amount of data that can be encoded in a single pattern, allowing them to include information such as the date of vaccine administration and the lot number of the vaccine batch.

The researchers believe the quantum dots are safe to use in this way because they are encapsulated in a biocompatible polymer, but they plan to do further safety studies before testing them in patients.

Storage, access, and control of medical records is an important topic with many possible approaches, says Mark Prausnitz, chair of chemical and biomolecular engineering at Georgia Tech, who was not involved in the research. This study presents a novel approach where the medical record is stored and controlled by the patient within the patients skin in a minimally invasive and elegant way.

The research was funded by the Bill and Melinda Gates Foundation and the Koch Institute Support (core) Grant from the National Cancer Institute. Other authors of the paper include Sean Severt, Mache Cruz, Morteza Sarmadi, Hapuarachchige Surangi Jayawardena, Collin Perkinson, Fridrik Larusson, Sviatlana Rose, Stephanie Tomasic, Tyler Graf, Stephany Tzeng, James Sugarman, Daniel Vlasic, Matthew Peters, Nels Peterson, Lowell Wood, Wen Tang, Jihyeon Yeom, Joe Collins, Philip Welkhoff, Ari Karchin, Megan Tse, Mingyuan Gao, and Moungi Bawendi.

Read more here:
Storing medical information below the skins... - ScienceBlog.com

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (AgeX; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced the drawdown of a $1.3 million tranche of financing pursuant to its unsecured loan facility from Juvenescence Limited.

Juvenescence is pleased to continue its commitment to AgeX through this additional drawdown under the loan facility, commented Gregory Bailey, MD, Chairman of AgeX and CEO of Juvenescence. Juvenescence remains committed to funding the future development plans of AgeX through further advancements under the loan facility or otherwise. Since Juvenescences initial investment in AgeX in June 2018, AgeX has been an important element in the Juvenescence mission and strategy. Juvenescence is also investing its time and personnel to support AgeXs business development initiatives which have impressive potential. We look forward to AgeX announcing its plans for 2020 as it pursues tissue regeneration in Reverse Bioengineering, while advancing the development of BAT and VASC 1, the coupling of HLA-G with PureStem-derived cells for transplant therapies, and exploring partnerships with third parties.

This round of funding will allow us to continue to execute on our strategic plan to provide therapies for certain chronic and degenerative diseases through cellular regeneration and replacement, commented AgeXs founder and CEO Michael D. West, PhD.

As announced in the companys news release on August 14, 2019, AgeX has obtained a $2 million credit facility from Juvenescence to finance AgeXs operations and advance its product development programs.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly-defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeX is developing its core product pipeline for use in the clinic to extend human healthspan and is seeking opportunities to establish licensing and collaboration agreements around its broad IP estate and proprietary technology platforms.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

Forward-Looking Statements

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

Visit link:
AgeX Therapeutics Announces Drawdown of Second Tranche of Loan Facility from Juvenescence Ltd. - Business Wire

Global Mixed Tocopherols Market Professional Survey Report 2019 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing capital structure of the Global Mixed Tocopherols Market. Some of the key players profiled in the study are Archer Daniels Midland, DSM, BASF, Dupont Danisco, Sigma Aldrich, Nutralliance, The Scoular, Vitae Naturals, B&D Nutrition Industries, Davos Life Science & Cofco Tech Bioengineering.

Mixed Tocopherols Market Overview:

If you are involved in the Mixed Tocopherols industry or intend to be, then this study will provide you comprehensive outlook. Its vital you keep your market knowledge up to date segmented by Food & Beverage, Feed, Dietary Supplements, Pharmaceuticals & Cosmetics, , Soybean Oil, Rapeseed Oil, Sunflower Oil & and Corn Oil and major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.

You can get free access to samples from the report here:https://www.htfmarketreport.com/sample-report/2154228-global-mixed-tocopherols-market-1

Mixed Tocopherols Market: Demand Analysis & Opportunity Outlook 2023

Research study is to define market sizes of various segments & countries in previous years and to forecast the values to the next 5-8 years. The report is designed to comprise each qualitative and quantitative elements of the industry facts including: market share, market size (value and volume 2012-17, and forecast to 2023) with admire to each of the areas and countries concerned inside the examination. Furthermore, the report additionally caters the detailed statistics about the vital elements which includes drivers & restraining factors which will define the future growth of the market.

Furthermore, the years considered for the study are as follows:Historical year 2013-2017Base year 2018Forecast period** 2018 to 2023 [** unless otherwise stated]

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

The designated segments and sub-section of the market are explained below:

The Study is segmented by following Product Type: , Soybean Oil, Rapeseed Oil, Sunflower Oil & and Corn Oil

Major applications/end-users industry are as follows: Food & Beverage, Feed, Dietary Supplements, Pharmaceuticals & Cosmetics

Some of the key Manufacturers Involved in the Market are Archer Daniels Midland, DSM, BASF, Dupont Danisco, Sigma Aldrich, Nutralliance, The Scoular, Vitae Naturals, B&D Nutrition Industries, Davos Life Science & Cofco Tech Bioengineering

Enquire for customization in Report @https://www.htfmarketreport.com/enquiry-before-buy/2154228-global-mixed-tocopherols-market-1

For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. If opting for the Global version of Mixed Tocopherols Market analysis is provided for major regions as follows: North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Buy this research report @https://www.htfmarketreport.com/buy-now?format=1&report=2154228

Key Answers Captured in Study areWhich geography would have better demand for product/services?What are the strategies adopted by big players in the regional market?Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?What is the current & expected market size in next five years?What is the market feasibility for long term investment?What opportunity the country would offer for existing and new players in the Mixed Tocopherols market?What is risk involved for suppliers in the geography?What factors would drive the demand for the product/service in near future?What is the impact analysis of various factors in the Global Mixed Tocopherols market growth?What are the recent trends in the regional market and how successful they are?

Read Detailed Index of full Research Study at @https://www.htfmarketreport.com/reports/2154228-global-mixed-tocopherols-market-1

There are 15 Chapters to display the Global Mixed Tocopherols market.Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Global Mixed Tocopherols market, Applications [Food & Beverage, Feed, Dietary Supplements, Pharmaceuticals & Cosmetics], Market Segment by Regions North America, Europe, China, Japan, Southeast Asia & India;Chapter 2, objective of the study.Chapter 3, to display Research methodology and techniques.Chapter 4 and 5, to show the Overall Market Analysis, segmentation analysis, characteristics;Chapter 6 and 7, to show the Market size, share and forecast; Five forces analysis (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;Chapter 8 and 9, to show analysis by regional segmentation[North America, Europe, China, Japan, Southeast Asia & India ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain AnalysisChapter 10, focus on identifying the key industry influencers, overview of decision framework accumulated through Industry experts and strategic decision makers;Chapter 11 and 12, Market Trend Analysis, Drivers, Challenges by consumer behaviour, Marketing Channels and demand & supply.Chapter 13 and 14, describe about the vendor landscape (classification and Market Positioning)Chapter 15, deals with Global Mixed Tocopherols Market sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand].

About Author:HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]

Connect with us atLinkedIn|Facebook|Twitter

This post was originally published on Info Street Wire

Continue reading here:
Mixed Tocopherols Market Analysis by Production, Revenue, Consumption, Export & Import Forecast 2025 - Info Street Wire

Global Cold Plasma Market is valued approximately at USD 1.30 billion in 2018 and is anticipated to grow with a healthy compounded growth rate of more than 15.6% over the forecast period 2019-2026. Cold plasma, which is also known as non-equilibrium plasma or non-thermal plasma, is a classification of plasma and is considered as the fourth state of matter. It has several applications in bioengineering, medical and therapeutics. It is mainly used for sterilization of biomedical surfaces, medication of living biological tissues, and surface variation of biomedical devices and materials, due to its antimicrobial & bactericidal properties. Rising cases of Hospital-Acquired Infections (HAIs), due to the lack of sanitation and precaution; increasing application of cold plasma in various industries and growing benefits of cold plasma technology are the few factors responsible for high CAGR of the market over the forecast period. For instance, according to theto the Centers for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one HAI every year. Similarly, according to the European Centre for Disease Prevention and Control, in 2015, 11,788 (around 8.0%) patients admitted in Intensive Care Unit (ICU) for over two days suffered from at least one ICU-developed HAI. Moreover, growing application of cold plasma in the medical industry along with growing demand from developing nations is the major factor which is likely to create lucrative growth opportunity to the market in the upcoming years. However, huge capital incurred for implementing cold plasma technology is one of the major factorfactors anticipated to limiting the growth of global Cold Plasma market during the forecast period.

The regional analysis of global Cold Plasma Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the early adoption of technologically advanced products, rise in demand for advanced procedures for various treatments, increasing HAI cases, and rising awareness about applications of cold plasma in medicine across the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026 due to the increasing demand for decontaminated frozen food, growing manufacturing facilities of textiles, and the rising production of polymers in the region.

Get a sample copy of this Report: https://www.digitsnmarkets.com/sample/5030-global-cold-plasma-market

Research Methodology:-

Our Company uses the following research methodology:Our team of experienced research professionals and consultants has developed an exhaustive research methodology. We use this methodology for all of our published reports. Various parameters such as Macro-Economic Factors, Micro-Economic Factors, Technology & Innovation, Value Chain and market dynamics are evaluated for each market.

Data Extraction:-

Data is extracted at an extensive level from various relevant sources and repository of reports. Some of the secondary sources such as ICIS, Hoovers, Trade Magazines, Associations, Reuters and others are being used.

Forecasting:-

Various modeling techniques such as Statistical Techniques and Forecasting are being used to estimate and forecast market data. Each regional market is evaluated separately. Market Dynamics of the domestic and international market is taken into consideration. Global data is evaluated after integrating regional data and information.

Primary Interviews and Expert Consultation:-

Our team conducts interviews to validate findings through secondary research. In order to understand recent trends and market dynamics, the team also conducts interviews with key business leaders such as CEOs, Technology Experts, Suppliers, and other experienced professionals.

Browse this full Report: https://www.digitsnmarkets.com/report/5030-global-cold-plasma-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits N Markets410 E Santa Clara Street, Unit #762San Jose, CA 95113Phone :+1 408-622-0123Email: sales@digitsnmarkets.comWebsite:- http://www.digitsnmarkets.com

Read the rest here:
Global Cold Plasma Market Size study, by Industry (Textile Industry, Polymer & Plastic Industry, Electronics & Semiconductor Industry, Food...

Juvenescence is pleased to continue its commitment to AgeX through this additional drawdown under the loan facility, commented Gregory Bailey, MD, Chairman of AgeX and CEO of Juvenescence. Juvenescence remains committed to funding the future development plans of AgeX through further advancements under the loan facility or otherwise. Since Juvenescences initial investment in AgeX in June 2018, AgeX has been an important element in the Juvenescence mission and strategy. Juvenescence is also investing its time and personnel to support AgeXs business development initiatives which have impressive potential. We look forward to AgeX announcing its plans for 2020 as it pursues tissue regeneration in Reverse Bioengineering, while advancing the development of BAT and VASC 1, the coupling of HLA-G with PureStem-derived cells for transplant therapies, and exploring partnerships with third parties.

This round of funding will allow us to continue to execute on our strategic plan to provide therapies for certain chronic and degenerative diseases through cellular regeneration and replacement, commented AgeXs founder and CEO Michael D. West, PhD.

As announced in the companys news release on August 14, 2019, AgeX has obtained a $2 million credit facility from Juvenescence to finance AgeXs operations and advance its product development programs.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly-defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeX is developing its core product pipeline for use in the clinic to extend human healthspan and is seeking opportunities to establish licensing and collaboration agreements around its broad IP estate and proprietary technology platforms.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

Forward-Looking Statements

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191226005045/en/

View post:
AgeX Therapeutics Announces Drawdown of Second Tranche of Loan Facility from Juvenescence Ltd. - BioSpace